Methods

Subjects
We recruited consecutive individuals with COPD who attended the pulmonary outpatient clinic, as well as COPD inpatients at the time of discharge, in the period of April-June 2006. Patients younger than 60 years of age were excluded. Exclusion criteria were also the co-existence of malignancies or other illnesses known to alter the nutritional state. All patients were in stable condition. The study was approved by the Ethics Committee of the University of Palermo, and all patients gave written, informed consent prior to participation.
Study design
The nutritional status was evaluated through anthropometric measurements and the MNA questionnaire; the perception of dyspnoea was assessed by the Modified Medical Research Council (MMRC) Dyspnoea Scale and the degree of physical disability by the Barthel Index. Clinical and functional evaluations were performed to assess the severity of COPD [16, 17] . The number of comorbid conditions was also recorded.
Nutritional and anthropometric data: weight, height, waist and hip circumferences were measured following a standardised procedure [18] . The MNA test is an internationally validated, two-step procedure (screening for risk of malnutrition followed by global assessment of the nutritional conditions), which evaluate the overall health status of elderly subjects, by rating cognitive function, functional status, walking, balance and socio-economic status [15] . The MNA provides a total score that ranges from 0 to 30 points. According to the score achieved, patients are classified as undernourished (≤17 points), at risk of malnutrition (17.5-23.5), and well nourished (>23.5). Subjects who attained >12 points at the screening were assigned an arbitrary value of 30. To avoid inter-observer variability, the MNA evaluation was performed only by one person (GP).
The perception of dyspnoea was assessed through the MMRC Dyspnoea Scale [4] by another investigator (LM). The MMRC Dyspnoea Scale consists of five grades of physical activities that provoke dyspnoea. The Barthel Index was used to establish the degree of physical performance [19] . The final score ranges from 0 (complete dependency) to 100 (complete independence).
Data analysis
Data are presented as mean ± SD or median and range, where appropriate. Unpaired t-test or Mann-Whitney test were employed to assess differences between the two groups ('well nourished' versus 'at risk of malnutrition') for anthropometric, functional and clinical variables. An ordinal regression analysis was performed to assess independent contributors to the variance in degree of dyspnoea (MMRC score). In all analyses, P values ≤0.05 were considered statistically significant.
Results
Thirty-two individuals with COPD were enrolled ( Table 1 ). All patients met the criteria for airflow obstruction (mean FEV 1 /VC: 0.48; range: 0.30-0.69). Ten patients were on long-term oxygen therapy. Ten patients were current smokers (pack-year: 67 ± 29, mean ± SD) and 22 ex-smokers (73 ± 45, mean ± SD). None of the patients was free of dyspnoea (MMRC, median: 3, range: 1-4). The Barthel Index was between 29 and 100 (median: 82), with only two patients showing complete independence (100 points). The BMI resulted in 27.8 ± 3.8 kg/m 2 , and the waist : hip ratio was 1.1 ± 0.1. The MNA score did not correlate with BMI (r = 0.20, P = 0.27), nor with the waist : hip ratio (r = 0.30, P = 0.15). The MNA classification led to the generation of two groups: 14 patients were classified as 'at risk of malnutrition', and 18 regarded as 'well nourished'. Age was not different between the two groups (at risk of malnutrition: 72 ± 5.3 years; well nourished: 71 ± 6.7 years, P = 0.58), nor was BMI (26.9 ± 4.1 kg/m 2 versus 28.5 ± 3.6 kg/m 2 , P = 0.29). The FEV 1 % predicted was significantly lower in patients at risk of malnutrition (41 ± 10% versus 51 ± 12%, respectively; P = 0.02). Subjects on oxygen therapy showed lower MNA than that of individuals on pharmacological therapy (20.9 ± 3.7 versus 27.5 ± 3.9, P<0.0001, respectively). The number of comorbid conditions did not differ between the two groups (P = 0.33), nor did the total number of medications used by the patients (P = 0.49). Similarly, the smoking habit was not different between groups (P = 0.69). The Barthel Index did not differ between the at risk (74 ± 19) and well nourished (79 ± 14) patients (P = 0.45). The severity of dyspnoea was significantly higher in patients at risk of malnutrition than in the well nourished group (3.1 ± 0.7 versus 2.3 ± 1.0, respectively; P = 0.02 by Mann-Whitney test) (Figure 1) . The ordinal regression analysis, in which the MMRC represented the dependent variable, and the MNA and FEV 1 % predicted the independent variables yielded a P value of 0.01, with the MNA being the only factor that entered the model (P = 0.05).
Discussion
The present study shows that elderly patients with COPD with normal BMI but at risk for malnutrition complain of a higher degree of dyspnoea compared to well nourished patients with COPD. This suggests that early alterations of the nutritional status may play a significant role in the perception of symptoms in elderly individuals with COPD, and implies that the early detection of nutritional impairment should be included in the clinical assessment of the disease.
To the best of our knowledge, this is the first attempt to use the MNA in a population of patients with COPD. The MNA has been validated in different populations: Magri et al. [20] detected a significant risk of malnutrition in hospitalized patients with dementia. The MNA was also evaluated in orthopaedic patients [21] , in surgical elderly patients [22] and in elderly, otherwise healthy subjects [23] . The reliability of the MNA in older patients was demonstrated by Barone et al. [24] , who found that the MNA was superior than the global assessment of healthy status in identifying malnourished patients. Taken together, these studies provide evidence that the MNA can be safely used in the assessment of elderly populations.
The finding that the perception of increased dyspnoea is associated with the risk of malnutrition supports and extends previous observations on the pathogenetic role of low body weight in patients with COPD [5] . Interestingly, a more severe degree of dyspnoea has been observed in patients with COPD with lower MNA scores, even in the absence of reduced BMI. To explain the observed correlation between increased sensation of dyspnoea and the risk of malnutrition, at least two mechanisms can be proposed. First, it has been demonstrated that quadriceps endurance is reduced in patients with COPD, even in the mild stage of the disease [25] . This weakness of skeletal muscle causes a reduction in the ability to perform physical exercise, and this may, in turn, account for a greater degree of breathlessness [25, 26] . Second, the increased sensation of dyspnoea could be related to the presence of more severe emphysema. If this is the case, dyspnoea and the risk of malnutrition could share common pathogenetic mechanisms. It has been demonstrated that COPD associated with highresolution computed tomography-documented emphysema is characterised by more severe lung function impairment, more intense airway inflammation, and, possibly, more serious systemic dysfunctioning, as compared with COPD free of HRCT-documented emphysema [27] . Therefore, nutritional alterations could be listed among the clinical manifestations of systemic inflammation in patients with COPD.
The study suffers from several limitations. First, the sample size is small, and consists of almost all males with severe forms of the disease. For these reasons, it cannot be regarded as representative of the COPD population. Secondly, the small number of subjects recruited might have also affected the statistical significance, or the lack of, for the findings. Therefore, a causative relationship between the malnutritional status and the perception of dyspnoea cannot be proposed. Rather, the findings of the study show an association between the two factors, which needs further elucidation.
In conclusion, the current study indicates that, even during the early phases, malnutrition is associated with increased perception of dyspnoea in older patients with COPD. The MNA can be easily performed in older patients to detect early changes in the nutritional status and, therefore, should be included in the comprehensive diagnostic assessment of COPD. Further longitudinal and interventional studies are strongly advocated.
Key points
• Nutritional abnormalities are recognised as systemic manifestation of COPD, but their contribution to the occurrence of respiratory symptoms is still unclear. The current study aimed at investigating whether differences in nutritional status can influence the perception of dyspnea in individuals with COPD. • Thirty-two elderly patients with COPD underwent assessment of their nutritional status through anthropometric measurements and the MNA questionnaire; the perception of dyspnea was assessed by the MMRC Dyspnea Scale.
• None of the patients was free of dyspnea. When patients were classified according to the level of MNA score, the severity of dyspnea was significantly greater in patients at risk of malnutrition than in the well nourished group. • The study shows that patients with COPD with normal BMI but at risk for malnutrition complain of a higher degree of dyspnea compared to well nourished patients with COPD. This finding suggests that early alterations in nutritional status may play a significant role in the perception of symptoms in individuals with COPD.
• Early detection of nutritional impairment should be included in the clinical assessment of elderly individuals with COPD. The aluminium content of bone, and mortality risk SIR-Even though aluminium is the commonest metal in the earth's crust, evolution has not conferred it with an essential biological function. The metal has been regarded as relatively biologically inert in the past. Aluminium is now considered to be a potentially toxic metal that might trigger apoptosis [1] . Aluminium poisoning may lead to three types of disorder: aluminium-induced bone disease, microcytic anaemia and encephalopathy, which is well known in patients with chronic renal failure [2] [3] [4] [5] [6] [7] . Induction of progressive central nervous system diseases has also been suggested, e.g. amyotrophic lateral sclerosis, Parkinson's disease [8, 9] and Alzheimer's dementia [10] [11] [12] .
Conflicts of interest
Aluminium normally enters the body through the diet owing to its natural presence in many foods, and from leaching into food by aluminium-containing cooking utensils. The total dietary intake has been estimated at 4-9 mg Al/day [13] [14] [15] , and 4% of the aluminium content of the diet is retained by intestinal absorption. This aluminium can partially be accumulated in bone-the main storage site of aluminium-for years under continuous intake conditions [16] . In the elderly, and especially in young patients with an Alzheimer-type pathology, the intestinal absorption of aluminium is increased [17, 18] , thus enhancing the putative bone-tissue accumulation.
Given that aluminium is exponentially accumulated in the body with ageing [19] , that aluminium is associated with neurodegenerative diseases, and that aluminium is linked to processes in the cell that eventually lead to premature cell death, the hypothesis of considering whether aluminium plays a role in the ageing process and is associated with mortality risk is warranted. This study was therefore performed in order to examine whether the aluminium content in bone in humans was associated with mortality risk.
Subjects and methods
A total of 198 patients-132 women and 66 men-with a mean age of 73 years and a range of 16-98 years were included in this study, and all characteristics are shown in Table 1 . They were treated at either of the two hospitals in the county of Uppsala, and admitted to the hospitals for either arthroplasty of the hip because of osteoarthritis (n = 50), shaft fractures of the femur (n = 9) or the tibia (n = 10), or hip fracture (n = 129). Of these hip-fractures cases, 62 had a diagnosis of dementia on admission to hospital, while none of the remaining 136 participants had this diagnosis. The Ethics Committee of the Medical Faculty of Uppsala University approved the study.
During the operations on all cases, bone biopsies from the trabecular bone of the proximal femur or from the proximal tibia were taken using an aluminium-free instrument. The bone samples were immediately put in sealed polyethylene test tubes, frozen and stored at −20
• C until analysis at a maximum of 6 months after the operation. Prior to analysis, after drying at 120
• C for 48 h the bone samples were weighed. The bone samples were then decomposed using ultra-pure nitric acid in a quartz tube, and an internal standard (Indium), diluted with high-purity water (with a resistivity of over 18 M -cm), was added. The samples were then introduced into an inductively coupled mass spectrometer (Perkin-Elmer Elan 6000) and measured for their content of aluminium (ng/g dry bone). All handling of the samples was carried out in a clean room. Quality control was assessed through use of a reference material (IAEA H-8 Animal bone) in every fifth sample, randomly distributed in the measurement series. 
